Galderma Group AG (SIX:GALD), the pure-play dermatology category leader, today announced its sales performance for the first quarter of 2026. “Galderma’s strong first quarter results reflect our ...

The Board of Directors proposes a dividend of 0.35 CHF per registered share of Galderma following its record 2025 performance. If approved by shareholders, the dividend will be paid out of reserves ...

Galderma completed one of the largest IPOs in Europe in 2024 Galderma is headquartered in Switzerland EQT carved out Galderma from Nestlé in October 2019 EQT has completed the final sell-down in ...

Galderma has significantly raised its peak annual sales estimate for Nemluvio (nemolizumab) to more than $4 billion, doubling its previous projection of more than $2 billion. The update follows what ...

L'Oréal is doubling its stake in Galderma to 20%, capitalizing on a strong market cap increase since its initial investment. A large portion of future earnings expectations is tied to Nemluvio, a drug ...

L’Oréal’s second purchase of a 10% stake in Galderma in a little over a year is estimated to be worth almost $5 billion at Galderma’s Monday closing share price. L’Oréal and Galderma have been keeping ...

L'Oreal doubles its stake in maker of injectable cosmetics Sector is growing by double-digits, consultancy says Company to gain two seats on Galderma board Dec 8 (Reuters) - L'Oreal will double its ...

PARIS — L’Oréal is delving deeper into aesthetics with the acquisition of another 10 percent stake in Galderma Group AG, the pure-play dermatology leader worldwide that’s among the largest in ...

Good day, and thank you for standing by. Welcome to Galderma's conference call. [Operator Instructions] Please be advised that this conference is being recorded. I would now like to hand the ...

Flemming Ørnskov, CEO, Galderma discusses the company's decision to raise its FY guidance, and explains why the U.S. is a key market for the business. Got a confidential news tip? We want to hear from ...

Dermatology specialist Galderma has hopped on the U.S. manufacturing bandwagon, revealing a commitment to spend more than $650 million through 2030 as it taps domestic contractors to produce newly ...

(Reuters) -Switzerland's Galderma raised its full-year guidance on Thursday after third-quarter sales beat expectations despite pressure from U.S. tariffs, sending shares in the skincare company up ...